190 related articles for article (PubMed ID: 9247094)
41. Five different enzymatic activities are associated with the multienzyme complex of fatty acid oxidation from Escherichia coli.
Pramanik A; Pawar S; Antonian E; Schulz H
J Bacteriol; 1979 Jan; 137(1):469-73. PubMed ID: 368024
[TBL] [Abstract][Full Text] [Related]
42. Medium-chain fatty acids undergo elongation before beta-oxidation in fibroblasts.
Jones PM; Butt Y; Messmer B; Boriak R; Bennett MJ
Biochem Biophys Res Commun; 2006 Jul; 346(1):193-7. PubMed ID: 16750167
[TBL] [Abstract][Full Text] [Related]
43. [Diagnostic approach and treatment of inherited mitochondrial fatty acid oxidation disorders].
Peña Quintana L; Sanjurjo Crespo P
An Esp Pediatr; 2001 Dec; 55(6):524-34. PubMed ID: 11730586
[TBL] [Abstract][Full Text] [Related]
44. Effect of high-intensity intermittent swimming training on fatty acid oxidation enzyme activity in rat skeletal muscle.
Terada S; Tabata I; Higuchi M
Jpn J Physiol; 2004 Feb; 54(1):47-52. PubMed ID: 15040848
[TBL] [Abstract][Full Text] [Related]
45. Ranolazine, a partial fatty acid oxidation (pFOX) inhibitor, improves left ventricular function in dogs with chronic heart failure.
Sabbah HN; Chandler MP; Mishima T; Suzuki G; Chaudhry P; Nass O; Biesiadecki BJ; Blackburn B; Wolff A; Stanley WC
J Card Fail; 2002 Dec; 8(6):416-22. PubMed ID: 12528095
[TBL] [Abstract][Full Text] [Related]
46. Characterization of L-aminocarnitine, an inhibitor of fatty acid oxidation.
Chegary M; Te Brinke H; Doolaard M; Ijlst L; Wijburg FA; Wanders RJ; Houten SM
Mol Genet Metab; 2008 Apr; 93(4):403-10. PubMed ID: 18077198
[TBL] [Abstract][Full Text] [Related]
47. Subcellular distribution of the enzymes of the fatty acyl-CoA beta-oxidation system and their induction by di(2-ethylhexyl)phthalate in rat liver.
Osumi T; Hashimoto T
J Biochem; 1979 Jan; 85(1):131-9. PubMed ID: 762039
[No Abstract] [Full Text] [Related]
48. Melanoma Persister Cells Are Tolerant to BRAF/MEK Inhibitors via ACOX1-Mediated Fatty Acid Oxidation.
Shen S; Faouzi S; Souquere S; Roy S; Routier E; Libenciuc C; André F; Pierron G; Scoazec JY; Robert C
Cell Rep; 2020 Nov; 33(8):108421. PubMed ID: 33238129
[TBL] [Abstract][Full Text] [Related]
49. Parenteral and enteral metabolism of anaplerotic triheptanoin in normal rats. II. Effects on lipolysis, glucose production, and liver acyl-CoA profile.
Gu L; Zhang GF; Kombu RS; Allen F; Kutz G; Brewer WU; Roe CR; Brunengraber H
Am J Physiol Endocrinol Metab; 2010 Feb; 298(2):E362-71. PubMed ID: 19903863
[TBL] [Abstract][Full Text] [Related]
50. Importance of the gamma-carboxyl group of glutamate-462 of the large alpha-subunit for the catalytic function and the stability of the multienzyme complex of fatty acid oxidation from Escherichia coli.
He XY; Deng H; Yang SY
Biochemistry; 1997 Jan; 36(1):261-8. PubMed ID: 8993342
[TBL] [Abstract][Full Text] [Related]
51. Metabolic control of muscle mitochondrial function and fatty acid oxidation through SIRT1/PGC-1alpha.
Gerhart-Hines Z; Rodgers JT; Bare O; Lerin C; Kim SH; Mostoslavsky R; Alt FW; Wu Z; Puigserver P
EMBO J; 2007 Apr; 26(7):1913-23. PubMed ID: 17347648
[TBL] [Abstract][Full Text] [Related]
52. Diacylglycerol acyltransferase 2 links glucose utilization to fatty acid oxidation in the brown adipocytes.
Irshad Z; Dimitri F; Christian M; Zammit VA
J Lipid Res; 2017 Jan; 58(1):15-30. PubMed ID: 27836993
[TBL] [Abstract][Full Text] [Related]
53. A new inhibitor of mitochondrial fatty acid oxidation.
Hashimoto T; Shindo Y; Souri M; Baldwin GS
J Biochem; 1996 Jun; 119(6):1196-201. PubMed ID: 8827458
[TBL] [Abstract][Full Text] [Related]
54. The activity of 3-hydroxyacyl-CoA epimerase is insufficient to account for the rate of linoleate oxidation in rat heart mitochondria. Evidence for a modified pathway of linoleate degradation.
Chu CH; Kushner L; Cuebas D; Schulz H
Biochem Biophys Res Commun; 1984 Jan; 118(1):162-7. PubMed ID: 6696754
[TBL] [Abstract][Full Text] [Related]
55. Comparison of metabolic fluxes of cis-5-enoyl-CoA and saturated acyl-CoA through the beta-oxidation pathway.
Tserng KY; Chen LS; Jin SJ
Biochem J; 1995 Apr; 307 ( Pt 1)(Pt 1):23-8. PubMed ID: 7717980
[TBL] [Abstract][Full Text] [Related]
56. Isohumulones modulate blood lipid status through the activation of PPAR alpha.
Shimura M; Hasumi A; Minato T; Hosono M; Miura Y; Mizutani S; Kondo K; Oikawa S; Yoshida A
Biochim Biophys Acta; 2005 Sep; 1736(1):51-60. PubMed ID: 16099209
[TBL] [Abstract][Full Text] [Related]
57. Perfluorodecanoic acid noncompetitively inhibits the peroxisomal enzymes enoyl-CoA hydratase and 3-hydroxyacyl-CoA dehydrogenase.
Borges T; Glauert HP; Robertson LW
Toxicol Appl Pharmacol; 1993 Jan; 118(1):8-15. PubMed ID: 8430427
[TBL] [Abstract][Full Text] [Related]
58. [Mass Screening for Inborn Errors of Metabolism].
Ito T
Rinsho Byori; 2015 Apr; 63(4):441-9. PubMed ID: 26536777
[TBL] [Abstract][Full Text] [Related]
59. Differentiation of long-chain fatty acid oxidation disorders using alternative precursors and acylcarnitine profiling in fibroblasts.
Roe DS; Yang BZ; Vianey-Saban C; Struys E; Sweetman L; Roe CR
Mol Genet Metab; 2006 Jan; 87(1):40-7. PubMed ID: 16297647
[TBL] [Abstract][Full Text] [Related]
60. Fatty acid metabolism in liver of rats treated with hypolipidemic sulphur-substituted fatty acid analogues.
Asiedu D; Aarsland A; Skorve J; Svardal AM; Berge RK
Biochim Biophys Acta; 1990 May; 1044(2):211-21. PubMed ID: 1971517
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
